Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,556,314,393
-$226,675,630 QoQ
Shares Held
34,576,070
+0.5% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#3
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International Investors holds $21,276,574,646 across 8 Drug Manufacturers - General names. AZN ranks #2 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,734,768 | $6,878,453,355 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
34,576,070 | $6,556,314,393 | |
| 3 | ABBV |
AbbVie Inc.
|
15,638,631 | $3,935,305,104 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,386,689 | $1,977,189,536 | |
| 5 | AMGN |
Amgen Inc
|
1,668,778 | $604,297,889 | |
| 6 | JNJ |
Johnson & Johnson
|
2,040,519 | $518,230,610 | |
| 7 | NVO |
Novo Nordisk A S
|
9,721,180 | $466,033,369 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,913,752 | $340,750,390 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,556,314,393 | 34,576,070 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $6,782,990,023 | 34,393,013 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||